However, A20 and ABIN-1 undergo posttranslational regulation and degradation in response to a variety of inflammatory stimuli (72–74), and A20 has been reported to be decreased at the protein level in the mucosa of IBD patients (75). The gene discussed is TNFAIP3; the disease is inflammatory bowel disease.